[go: up one dir, main page]

NO20016038L - Benzenderivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme - Google Patents

Benzenderivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme

Info

Publication number
NO20016038L
NO20016038L NO20016038A NO20016038A NO20016038L NO 20016038 L NO20016038 L NO 20016038L NO 20016038 A NO20016038 A NO 20016038A NO 20016038 A NO20016038 A NO 20016038A NO 20016038 L NO20016038 L NO 20016038L
Authority
NO
Norway
Prior art keywords
processes
preparation
same
pharmaceutical compositions
compositions containing
Prior art date
Application number
NO20016038A
Other languages
English (en)
Other versions
NO327778B1 (no
NO20016038D0 (no
Inventor
Robert Boigegrain
Bernard Bourrie
Martine Bourrie
Pierre Casellas
Jean Marc Herbert
Pierre Lair
Dino Nisato
Raymond Paul
Jean Claude Vernieres
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20016038D0 publication Critical patent/NO20016038D0/no
Publication of NO20016038L publication Critical patent/NO20016038L/no
Publication of NO327778B1 publication Critical patent/NO327778B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/34—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton
    • C07C211/35—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of a saturated carbon skeleton containing only non-condensed rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
    • C07C211/40—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing only non-condensed rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20016038A 1999-06-11 2001-12-10 Benzenderivater, fremgangsmate for deres fremstilling, farmasoytiske preparater inneholdende de samme samt deres anvendelse NO327778B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9907396A FR2794742B1 (fr) 1999-06-11 1999-06-11 Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant
PCT/FR2000/001575 WO2000076953A1 (fr) 1999-06-11 2000-06-08 Derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant

Publications (3)

Publication Number Publication Date
NO20016038D0 NO20016038D0 (no) 2001-12-10
NO20016038L true NO20016038L (no) 2002-02-11
NO327778B1 NO327778B1 (no) 2009-09-21

Family

ID=9546664

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016038A NO327778B1 (no) 1999-06-11 2001-12-10 Benzenderivater, fremgangsmate for deres fremstilling, farmasoytiske preparater inneholdende de samme samt deres anvendelse

Country Status (33)

Country Link
US (1) US6482986B1 (no)
EP (1) EP1192122B1 (no)
JP (1) JP4711579B2 (no)
KR (1) KR100668581B1 (no)
CN (1) CN1210250C (no)
AR (1) AR033793A1 (no)
AT (1) ATE252542T1 (no)
AU (1) AU768420B2 (no)
BR (1) BR0011738A (no)
CA (1) CA2374631C (no)
CO (1) CO5180554A1 (no)
CZ (1) CZ299659B6 (no)
DE (1) DE60006113T2 (no)
DK (1) DK1192122T3 (no)
ES (1) ES2208345T3 (no)
FR (1) FR2794742B1 (no)
HK (1) HK1042891B (no)
HU (1) HU228683B1 (no)
IL (1) IL146545A0 (no)
MX (1) MXPA01012783A (no)
NO (1) NO327778B1 (no)
NZ (1) NZ515529A (no)
PL (1) PL196491B1 (no)
PT (1) PT1192122E (no)
RS (1) RS49998B (no)
RU (1) RU2248964C2 (no)
SI (1) SI1192122T1 (no)
SK (1) SK286390B6 (no)
TW (1) TWI279398B (no)
UA (1) UA71959C2 (no)
UY (1) UY26199A1 (no)
WO (1) WO2000076953A1 (no)
ZA (1) ZA200109486B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110750A1 (de) * 2001-03-07 2002-09-12 Bayer Ag Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften
GB2410947B (en) * 2004-02-11 2008-09-17 Cambridge Lab Ltd Pharmaceutical compounds
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
EP1634598A1 (en) * 2004-09-07 2006-03-15 Laboratorios Del Dr. Esteve, S.A. Use of piperazine derivatives and analogues for the manufacture of a medicament for the prophylaxis and/or treatment of disorders of food ingestion
EP1896413B1 (en) * 2005-03-28 2015-04-22 Semiconductor Energy Laboratory Co., Ltd. Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device
FR2887454B1 (fr) * 2005-06-28 2009-06-05 Sanofi Aventis Sa Combinaisons antitumorales contenant des derives du taxane et des sigma ligands
GB0514501D0 (en) * 2005-07-14 2005-08-24 Cambridge Lab Ireland Ltd Pharmaceutical compounds
GB0516168D0 (en) * 2005-08-05 2005-09-14 Cambridge Lab Ireland Ltd Pharmaceutical compounds
US7731377B2 (en) * 2006-03-21 2010-06-08 Semiconductor Energy Laboratory Co., Ltd. Backlight device and display device
WO2008026614A1 (en) * 2006-08-30 2008-03-06 Semiconductor Energy Laboratory Co., Ltd. Method for synthesizing anthracene derivative and anthracene derivative, light emitting element, light emitting device, electronic device
GR1005865B (el) * 2007-01-17 2008-04-07 Anavex Life Sciences Corp. Νεοι συνδετες των σιγμα υποδοχεων με αντι-αποπτωτικες και/η προ-αποπτωτικες ιδιοτητες επι των κυτταρικων βιοχημικων μηχανισμων, με νευρο-προστατευτικη, αντικαρκινικη, αντι-μεταστατικη και αντι- αντι-(χρονιο)φλεγμονικη δραση.
US7723722B2 (en) 2007-03-23 2010-05-25 Semiconductor Energy Laboratory Co., Ltd. Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative
FR2915994B1 (fr) * 2007-05-11 2009-07-03 Galderma Res & Dev Procede de synthese de l'acide (z)-3-[2-butoxy-3'-(3-heptyl-1-methyl-ureido)-biphenyl-4-yl] -2-methoxy-acrylique.
US20080286445A1 (en) * 2007-05-17 2008-11-20 Semiconductor Energy Laboratory Co., Ltd. Composition, and method of fabricating light-emitting element
RU2349579C1 (ru) * 2007-07-09 2009-03-20 Институт нефтехимии и катализа РАН Способ получения n,n-диметил-3-фенил-2-пропин-1-амина
GB0810857D0 (en) * 2008-06-13 2008-07-23 Cambridge Lab Ireland Ltd Pharmaceutical compounds
WO2010005066A1 (en) * 2008-07-08 2010-01-14 Semiconductor Energy Laboratory Co., Ltd. Carbazole derivative, light-emitting element material, light-emitting element, and light-emitting device
US20110053866A1 (en) * 2008-08-12 2011-03-03 Biovail Laboratories International (Barbados) S.R.L. Pharmaceutical compositions
GB2462611A (en) * 2008-08-12 2010-02-17 Cambridge Lab Pharmaceutical composition comprising tetrabenazine
GB2463451A (en) * 2008-09-08 2010-03-17 Cambridge Lab 3, 11b cis-dihydrotetrabenazine compounds for use in the treatment of dementia
GB2463283A (en) * 2008-09-08 2010-03-10 Cambridge Lab 3,11b-cis-dihydrotetrabenazine for use in treating asthma
GB2463452A (en) * 2008-09-08 2010-03-17 Cambridge Lab Desmethyl derivatives of tetrabenazine and pharmaceutical compositions thereof
KR101661328B1 (ko) * 2008-09-19 2016-09-29 가부시키가이샤 한도오따이 에네루기 켄큐쇼 카르바졸 유도체 및 그 제조 방법
US8349898B2 (en) 2008-11-18 2013-01-08 Wisconsin Alumni Research Foundation Sigma-1 receptor ligands and methods of use
GR1006794B (el) * 2009-02-26 2010-06-04 Αλεξανδρος Βαμβακιδης Προσδετες των σιγμα υποδοχεων, αντι-αποπτωτικες και προ-αποπτωτικες ιδιοτητες επι των κυτταρικων μηχανισμων, και με πρωτοτυπη κυτταρο-προστατευτικη αλλα και αντικαρκινικη δραση
KR102225715B1 (ko) * 2013-07-09 2021-03-09 토소가부시키가이샤 아다만틸기를 가진 환상 아진 화합물, 제조 방법, 및 상기 화합물을 구성 성분으로서 함유하는 유기 전계발광소자
KR102844041B1 (ko) 2016-02-26 2025-08-11 가부시키가이샤 한도오따이 에네루기 켄큐쇼 유기 화합물, 발광 소자, 발광 장치, 전자 기기, 및 조명 장치
MA53246A (fr) 2016-07-27 2021-07-28 Univ Case Western Reserve Composés et procédés pour favoriser la myélinisation
WO2019126759A1 (en) * 2017-12-22 2019-06-27 Convelo Therapeutics, Inc. Compounds and methods of promoting myelination
WO2019126702A1 (en) 2017-12-22 2019-06-27 Case Western Reserve University Compounds for promoting myelination
CA3229664A1 (en) * 2021-08-23 2023-03-02 William A. DONALDSON Synthesis and evaluation of novel (4-hydroxyphenyl) substituted carbocycles as potent and selective estrogen receptor beta agonists

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4104383A (en) * 1973-11-02 1978-08-01 C M Industries Derivatives of phenylpropenylamine
FR2641276B1 (fr) 1988-12-30 1991-07-12 Sanofi Sa Derives du benzene, leur preparation et les compositions pharmaceutiques en contenant
WO1991009594A1 (en) * 1989-12-28 1991-07-11 Virginia Commonwealth University Sigma receptor ligands and the use thereof
ZA909902B (en) * 1989-12-21 1991-10-30 Himont Inc Graft copolymers of polyolefins and a method of producing same
FR2663328B1 (fr) 1990-06-14 1994-08-05 Sanofi Sa Derives d'hexahydroazepines, un procede pour leur preparation et compositions pharmaceutiques les contenant.
PT100639A (pt) * 1991-06-27 1993-09-30 Univ Virginia Commonwealth Metodo para o tratamento terapeutico com compostos que sao ligandos ao receptor sigma e compostos ai utilizados, nomeadamente derivados fenilalquil-amina, aminotetralina,piperazina e piperidina
US5449639A (en) 1994-10-24 1995-09-12 Taiwan Semiconductor Manufacturing Company Ltd. Disposable metal anti-reflection coating process used together with metal dry/wet etch
FR2751645B1 (fr) * 1996-07-29 1998-12-24 Sanofi Sa Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales

Also Published As

Publication number Publication date
RU2248964C2 (ru) 2005-03-27
SK286390B6 (sk) 2008-09-05
IL146545A0 (en) 2002-07-25
DE60006113D1 (de) 2003-11-27
ES2208345T3 (es) 2004-06-16
JP2003502306A (ja) 2003-01-21
US6482986B1 (en) 2002-11-19
PL196491B1 (pl) 2008-01-31
TWI279398B (en) 2007-04-21
HUP0201953A2 (hu) 2002-12-28
RS49998B (sr) 2008-09-29
CO5180554A1 (es) 2002-07-30
JP4711579B2 (ja) 2011-06-29
UY26199A1 (es) 2001-01-31
FR2794742A1 (fr) 2000-12-15
CZ299659B6 (cs) 2008-10-08
BR0011738A (pt) 2002-03-05
CN1210250C (zh) 2005-07-13
AR033793A1 (es) 2004-01-07
CN1355782A (zh) 2002-06-26
PT1192122E (pt) 2004-03-31
CA2374631C (en) 2010-10-19
KR100668581B1 (ko) 2007-01-17
ZA200109486B (en) 2002-11-18
NO327778B1 (no) 2009-09-21
FR2794742B1 (fr) 2005-06-03
NO20016038D0 (no) 2001-12-10
WO2000076953A1 (fr) 2000-12-21
EP1192122B1 (fr) 2003-10-22
SI1192122T1 (en) 2004-04-30
HK1042891B (zh) 2004-04-08
HU228683B1 (en) 2013-05-28
AU768420B2 (en) 2003-12-11
PL352742A1 (en) 2003-09-08
DE60006113T2 (de) 2004-07-15
HUP0201953A3 (en) 2006-03-28
YU87101A (sh) 2004-07-15
CZ20014443A3 (cs) 2002-05-15
NZ515529A (en) 2004-01-30
EP1192122A1 (fr) 2002-04-03
MXPA01012783A (es) 2002-09-18
DK1192122T3 (da) 2004-03-01
ATE252542T1 (de) 2003-11-15
CA2374631A1 (en) 2000-12-21
UA71959C2 (en) 2005-01-17
KR20020009632A (ko) 2002-02-01
SK18062001A3 (sk) 2002-05-09
AU5539600A (en) 2001-01-02
HK1042891A1 (en) 2002-08-30

Similar Documents

Publication Publication Date Title
NO20016038L (no) Benzenderivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme
NO20024175D0 (no) Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme
NO20001409D0 (no) Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger
EE04464B1 (et) Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
NO20011216L (no) Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene
NO20014013D0 (no) 16-halogenepotilonderivater, fremgangsmater for fremstilling av dem og deres farmasoytiske anvendelse
EE04275B1 (et) Kinoliini derivaadid, nende valmistamismeetodid, kasutamine ja farmatseutilised kompositsioonid
NO20020684L (no) 3(5)-aminopyrazolderivater, fremgangsmåtet for deres fremstilling og deres anvendelse som antitumormidler
EE200200095A (et) Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod
NO20015175L (no) Farmasöytisk sammensetning
EE200200486A (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, uued derivaadid ja nende valmistamismeetodid
IL144501A0 (en) Epothilone derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
FI991485L (fi) Uusi farmaseuttinen koostumus
IL154096A0 (en) Aporphine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
DK1183256T3 (da) Puridinderivater, fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger, der indeholder dem
NO20016404L (no) Naftyridinderivater, fremgangsmåter for deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
DK1228039T3 (da) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmaceutiske præparater, der omfatter dem
NO960272L (no) Oksatiolaner, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder de samme
DK1118610T3 (da) Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
FI4488U1 (fi) Farmaseuttinen koostumus
NO20013878D0 (no) (1-fenacy-3-fenyl-3-piperidylety1)piperidin-derivater, fremgangsmate for fremstilling derav og farmasoytiske preparaterinneholdende de samme
NO20014803D0 (no) Pyrido-tieno-diazepiner, fremgangsmåte for fremstilling derav og farmasöytiske blandinger inneholdende dem
EE04525B1 (et) Morfoliini derivaadid, nende valmistamismeetod janeid sisaldavad farmatseutilised kompositsioonid
IL154986A0 (en) Triazolo-epothilone derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees